Macmillan Cancer Support warns of increasing challenges in UK cancer treatment, highlighting rising patient concerns, systemic strain, and widening regional disparities amid a growing cancer prevalence.
The number of cancer patients in the UK raising concerns about their care is increasing significantly, according to the chief executive of Macmillan Cancer Support. Gemma Peters highlighted emerging issues such as delays in diagnosis, difficulties in getting GP appointments, and lengthy waits for treatment as growing challenges within the system. She described Macmillan as a “safety net” for those experiencing problems but warned that the cancer care system remains under serious strain, with administrative pressures preventing it from fully meeting patient needs.
Macmillan’s latest annual report reveals that the charity supported more than 2.4 million people affected by cancer in 2024, up from 2.3 million in the prior year, spending £150.4 million on services. The charity’s network has also expanded, now including 11,000 professionals who provide tailored support throughout the cancer journey—a number that grew by 1,000 in 2024 alone. Peters noted the complexity of needs has increased alongside a rising cancer prevalence, with nearly 3.5 million people living with the disease in the UK, and that number expected to approach 4 million soon.
The rising prevalence underscores an urgent need for systemic improvements in cancer care, as many patients report finding cancer more difficult to live with than ever before. According to a survey conducted by YouGov for Macmillan, around 40% of cancer patients in the UK have chosen to travel to different hospitals seeking shorter waits or better treatment options, reflecting significant inequities in access to timely and effective care depending on where individuals live. These findings add further pressure on policymakers to address regional disparities in cancer services.
Macmillan’s five-year strategy, shaped by input from patients, healthcare professionals, and volunteers, aims to tackle these challenges head-on. Peters expressed confidence in the strategy’s focus on areas promising the greatest impact, such as expanding professional support across the country. However, she emphasised that despite positive steps, the charity remains cautious, acknowledging the persistent financial and operational pressures on the cancer care system—a system still “teetering at crisis point” in many respects.
The charity awaits the publication of a national cancer plan later this year with anticipation, hoping for a robust response that puts patients’ needs at the centre. With the number of people living with cancer continuing to rise, and access difficulties becoming more pronounced, Macmillan’s role as both advocate and direct provider of support looks set to remain crucial in navigating these complex challenges.
📌 Reference Map:
Source: Noah Wire Services
Noah Fact Check Pro
The draft above was created using the information available at the time the story first
emerged. We’ve since applied our fact-checking process to the final narrative, based on the criteria listed
below. The results are intended to help you assess the credibility of the piece and highlight any areas that may
warrant further investigation.
Freshness check
Score:
8
Notes:
The narrative references Macmillan Cancer Support’s annual report for 2024, which is not yet publicly available. The latest available report is for 2023, indicating that the 2024 report may not have been published at the time of writing. This suggests the article may be based on a press release or internal information, which typically warrants a high freshness score. However, the absence of the 2024 report raises questions about the accuracy of the reported figures. Additionally, the article includes updated data but recycles older material, which may justify a higher freshness score but should still be flagged. ([macmillan.org.uk](https://www.macmillan.org.uk/about-us/organisation/annual-reports?utm_source=openai))
Quotes check
Score:
7
Notes:
The article includes direct quotes from Gemma Peters, Chief Executive of Macmillan Cancer Support. A search for these quotes reveals no exact matches in earlier material, suggesting they may be original or exclusive content. However, without confirmation from the 2024 report, the accuracy of these quotes cannot be fully verified.
Source reliability
Score:
6
Notes:
The narrative originates from The Irish News, a reputable news outlet. However, the reliance on unpublished internal reports or press releases introduces uncertainty regarding the accuracy and reliability of the information presented.
Plausability check
Score:
7
Notes:
The claims about increasing concerns among cancer patients align with known challenges in the UK’s healthcare system. However, the specific figures and statements attributed to Gemma Peters cannot be fully verified due to the unavailability of the 2024 report. The article’s reliance on unpublished data raises questions about the plausibility of the reported figures.
Overall assessment
Verdict (FAIL, OPEN, PASS): OPEN
Confidence (LOW, MEDIUM, HIGH): MEDIUM
Summary:
The narrative presents concerning trends in cancer care, citing figures and quotes that cannot be fully verified due to the unavailability of Macmillan Cancer Support’s 2024 annual report. The reliance on unpublished internal reports or press releases introduces uncertainty regarding the accuracy and reliability of the information presented. While the claims are plausible, the lack of verifiable sources necessitates further scrutiny.
